Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-30

Study Completion Date

2019-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to establish the rationale for the practice of performing an oral reintroduction test without previous skin tests in children at low risk of IgE-mediated reaction or drug-induced toxidermia, and to confirm the criteria for a drug reintroduction test could be performed without previous skin tests, without subsequent risk of reaction for the child. The primary endpoint will be the risk of a severe IgE-mediated or delayed hypersensitivity reaction in children who received beta-lactam drug reintroduction protocol prior to skin testing.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Diagnosis of Beta-lactam Hypersensitivity in Thailand

NCT01667055

Penicillin Allergy Aminopenicillin Allergy Beta Lactam Adverse Reaction

COMPLETED

Penicillin Skin Testing in Patients With History of Allergic Reactions to Betalactams

NCT00789217

Penicillin Allergy

COMPLETED NA

Allergy to Almond in Children

NCT04407104

Food Allergy in Children

UNKNOWN

Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy

NCT04441021

Penicillin Allergy

COMPLETED

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

NCT06406114

Drug Allergy Cephalosporin Allergy Drug Hypersensitivity +4 more

RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypersensitivity Beta Lactam Adverse Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children under 16 years of age coming for a consultation for a beta-lactam oral reintroduction test.

Exclusion Criteria

* Refusal of the legal representatives of the subject for their child to participate in the study,
* If his age permits, refusal of the subject to participate in the study,
* Subject aged over 16,
* Pregnancy,
* Absence of affiliation of the subject to a social security scheme,
* Skin tests with incriminated beta-lactam already made before the consultation,
* Existence of contraindications to the realization of oral reintroduction drug test with the suspected antibiotic,
* Existence of criteria in the initial reaction suggestive of a non-low risk of IgE-mediated or delayed hypersensitivity to the incriminated beta-lactam, Taking antihistamine, corticosteroids or beta-blockers within 5 days prior to the oral reintroduction drug test,
* Travel abroad of the child scheduled within 7 days of the oral reintroduction drug test.

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes